Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Preanesthesia consultation for renal transplant recipients

Hendrikus J M Lemmens, MD, PhD
Section Editors
Michael Avidan, MD
Daniel C Brennan, MD, FACP
Deputy Editors
Nancy A Nussmeier, MD, FAHA
Alice M Sheridan, MD


After progression to end-stage renal disease (ESRD), renal transplantation is the treatment of choice, and is the most commonly performed organ transplantation. Compared with maintenance dialysis, successful transplantation improves quality of life and reduces mortality risk for most patients. (See "Evaluation of the potential renal transplant recipient".)

This topic reviews the preanesthesia consultation for patients undergoing renal transplantation. Anesthetic management in the intraoperative and early postoperative periods is discussed elsewhere. (See "Anesthesia for renal transplantation".)

Medical evaluation of a renal transplant recipient, issues related to dialysis in these patients before and after the surgical procedure, and complications following transplantation (eg, graft failure and mortality) are discussed separately:

(See "Evaluation of the potential renal transplant recipient".)

(See "Dialysis issues prior to and after renal transplantation".)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Oct 2017. | This topic last updated: Aug 14, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Gennari FJ, Segal AS. Hyperkalemia: An adaptive response in chronic renal insufficiency. Kidney Int 2002; 62:1.
  2. Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 2013; 309:678.
  3. US Food and Drug Administration. Hydroxyethyl starch solutions: FDA safety communication - boxed warning on increased mortality and severe renal injury and risk of bleeding. 2013. www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm358349.htm (Accessed on November 17, 2014).
  4. Ciapetti M, di Valvasone S, di Filippo A, et al. Low-dose dopamine in kidney transplantation. Transplant Proc 2009; 41:4165.
  5. Jalal DI, Chonchol M, Targher G. Disorders of hemostasis associated with chronic kidney disease. Semin Thromb Hemost 2010; 36:34.
  6. Pivalizza EG, Abramson DC, Harvey A. Perioperative hypercoagulability in uremic patients: a viscoelastic study. J Clin Anesth 1997; 9:442.
  7. Lentine KL, Costa SP, Weir MR, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation. Circulation 2012; 126:617.
  8. Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 130:2215.
  9. Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014; 35:2383.
  10. Higashi M, Yamaura K, Ikeda M, et al. Diastolic dysfunction of the left ventricle is associated with pulmonary edema after renal transplantation. Acta Anaesthesiol Scand 2013; 57:1154.
  11. Trainor D, Borthwick E, Ferguson A. Perioperative management of the hemodialysis patient. Semin Dial 2011; 24:314.
  12. Fidler S, Swaminathan R, Lim W, et al. Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss. Transpl Immunol 2013; 29:22.
  13. McAdams-DeMarco MA, Law A, King E, et al. Frailty and mortality in kidney transplant recipients. Am J Transplant 2015; 15:149.
  14. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56:M146.